Features BMS CA116-003 FR
You are invited to participate in the Bristol Myers Squibb CA116-003 study.
This app is specifically intended to capture MORAb-202 (farletuzumab etceteribulin) reactions and symptoms.
France participants only.
📚
Learning Tools
Enhance your learning experience with interactive features.
Screenshots
See the BMS CA116-003 FR in Action
Get the App Today
Download on Google Play
Available for Android 8.0 and above